Javier Olazarán

Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease

Javier Olazarán, ‌Barry Reisberg, Teodoro del Ser et al. · Neurology · 2004 · 293 citations

Medicine, Geriatric Medicine, Neurology +17

Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease

Daniel Alcolea, Pablo Martínez‐Lage, Pascual Sánchez‐Juan et al. · Neurology · 2015 · 164 citations

Life Sciences, Neurology, Neuroscience +17

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

Merçé Boada, Oscar L. López, Javier Olazarán et al. · Alzheimer s & Dementia · 2020 · 132 citations · Full text

Medicine, Geriatric Medicine, Neurology +13

A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease

Javier Olazarán, Luis Gil‐de‐Gómez, Andrés Rodríguez‐Martín et al. · Journal of Alzheimer s Disease · 2015 · 116 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial

Merçé Boada, Fernando Anaya, Pilar Ortiz et al. · Journal of Alzheimer s Disease · 2016 · 91 citations · Full text

Medicine, Neurology, Neuroscience +17